Kodjikian, Laurent <br/><br/>
Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials.  [electronic resource] 

 -  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie  Oct 2014 
 - 1529-37 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1435-702X 
<br/><br/><label>Standard No.: </label>10.1007/s00417-014-2764-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Bevacizumab<br/>Humans<br/>Randomized Controlled Trials as Topic<br/>Ranibizumab<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Wet Macular Degeneration--drug therapy